Moreover, urinary TNF-α and soluble TNF receptors 1 and 2 (TNFR1 and TNFR2) have been shown to be significant predictors of GFR decline in DM2 patients [32, 33]. Here, TNFRSF1B is linked to myotonic dystrophy type 2.